Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/6/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Maria T. Abreu

Wrong Dr. Maria T. Abreu?

Chair

Underrepresented Minorities Committee of the AGA
 
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • medical degree
    University of Miami School of Medicine
  • M.D.
  • undergraduate and medical degrees
    University of Miami
  • American Board of Gastroenterology
  • National Board of Medical Examiners
  • American Board of Internal Medicine
163 Total References
Web References
Maria T. Abreu, ...
www.gihealthfoundation.org, 6 Feb 2014 [cached]
Maria T. Abreu, MD Vice President Chief, Division of Gastroenterology
...
Maria T. Abreu obtained her medical degree through the Honors Program in Medical Education at the University of Miami School of Medicine. While in medical school, she served as Student Council President and was inducted into the Iron Arrow Honor Society the highest honor at the University of Miami. After completing her medical degree, she did her internship and residency in medicine at the Brigham and Women's Hospital in Boston, Massachusetts followed by a clinical and research fellowship in gastroenterology at the University of California, Los Angeles (UCLA). Following her fellowship, she obtained further postdoctoral training in molecular and cancer biology at UCLA. Her first independent research laboratory was at Cedars-Sinai Medical Center where she served as Director of Basic and Translational Research. Dr. Abreu was then recruited to the Mount Sinai School of Medicine in New York where she served as Director of the Inflammatory Bowel Disease (IBD) Center. While at Mount Sinai Dr. Abreu started the largest effort there to date to create an Inflammatory Bowel Disease database and tissue repository that collected over 2000 samples in a two-year period. In 2008, Dr. Abreu began her current position as Chief of Gastroenterology and Professor of Medicine at the University of Miami Miller School of Medicine. She is the Martin Kalser Chair in Gastroenterology.
A Diplomate of the National Board of Medical Examiners, The American Board of Internal Medicine, and the American Board of Gastroenterology, Dr. Abreu holds key positions with several professional societies. She is the Chair of the Underrepresented Minorities Committee of the AGA; Vice-Chair of the Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section of the AGA Institute Council and is a member of the AGA Public Affairs and Advisory Committee. Dr. Abreu is on the Women's Committee of the ACG. She is an active member of the Crohn's and Colitis Foundation of America (CCFA) and is on the Board of the Florida Chapter of the CCFA. In 2009, Dr. Abreu was recognized by the CCFA Florida Chapter for her education, support, and advocacy and in 2010 was the recipient of the chapter's Hope Award for her dedication to the treatment of patients with Crohn's disease and ulcerative colitis. She was recently selected Co-Director of the 2011 Spring Post Graduate course for the AGA, and was also named President-Elect of the Florida Gastroenterology Society. Dr. Abreu was elected to the American Society for Clinical Investigation in 2010, an honor society for physician-scientists. She is listed in Castle and Connelly as one of America's Top Doctors, and is a Fellow of the American College of Physicians and the American Gastroenterological Association.
Dr. Abreu has authored more than 100 peer-reviewed articles, books, chapter's and reviews. She serves on the editorial board of Inflammatory Bowel Diseases and Gastroenterology & Hepatology News, an AGA-sponsored publication. Dr. Abreu is an editor for the Journal of Immunology and is a reviewer for Gastroenterology and Nature Medicine, in addition to many other journals. She is a standing member of the NIH Gastrointestinal Mucosal Pathobiology Study Section (GMPB) and is a member of the CCFA Research Initiatives Committee. Her research interest is host-bacterial interactions and, in particular, the role of toll-like receptor signaling in intestinal inflammation and colon cancer. Her translational work has focused on genotype-phenotype relationships in inflammatory bowel disease and prediction of response to medical therapies. Dr. Abreu is a frequent speaker at national and international symposia on basic science and clinical topics.
...
Maria Abreu, MD
We would like to welcome the ...
www.gastro.org, 28 June 2010 [cached]
We would like to welcome the newly elected Immunology, Microbiology & Inflammatory Bowel Diseases Section Vice-Chair, Maria T. Abreu, MD.
...
Maria Abreu, Scott Plevy
...
Maria T. Abreu, MD Vice-Chair, IMIBD Section, AGA Institute Council
...
Maria T. Abreu, MD
:: GastroIntestinal Health Foundation ::
www.gihealthfoundation.org, 14 May 2013 [cached]
Maria T. Abreu, MD Vice President Chief, Division of Gastroenterology
...
Maria T. Abreu obtained her medical degree through the Honors Program in Medical Education at the University of Miami School of Medicine. While in medical school, she served as Student Council President and was inducted into the Iron Arrow Honor Society-the highest honor at the University of Miami. After completing her medical degree, she did her internship and residency in medicine at the Brigham and Women's Hospital in Boston, Massachusetts followed by a clinical and research fellowship in gastroenterology at the University of California, Los Angeles (UCLA). Following her fellowship, she obtained further postdoctoral training in molecular and cancer biology at UCLA. Her first independent research laboratory was at Cedars-Sinai Medical Center where she served as Director of Basic and Translational Research. Dr. Abreu was then recruited to the Mount Sinai School of Medicine in New York where she served as Director of the Inflammatory Bowel Disease (IBD) Center. While at Mount Sinai Dr. Abreu started the largest effort there to date to create an Inflammatory Bowel Disease database and tissue repository that collected over 2000 samples in a two-year period. In 2008, Dr. Abreu began her current position as Chief of Gastroenterology and Professor of Medicine at the University of Miami Miller School of Medicine. She is the Martin Kalser Chair in Gastroenterology.
A Diplomate of the National Board of Medical Examiners, The American Board of Internal Medicine, and the American Board of Gastroenterology, Dr. Abreu holds key positions with several professional societies. She is the Chair of the Underrepresented Minorities Committee of the AGA; Vice-Chair of the Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section of the AGA Institute Council; and is a member of the AGA Public Affairs and Advisory Committee. Dr. Abreu is on the Women's Committee of the ACG. She is an active member of the Crohn's and Colitis Foundation of America (CCFA) and is on the Board of the Florida Chapter of the CCFA. In 2009, Dr. Abreu was recognized by the CCFA Florida Chapter for her education, support, and advocacy and in 2010 was the recipient of the chapter's Hope Award for her dedication to the treatment of patients with Crohn's disease and ulcerative colitis. She was recently selected Co-Director of the 2011 Spring Post Graduate course for the AGA, and was also named President-Elect of the Florida Gastroenterology Society. Dr. Abreu was elected to the American Society for Clinical Investigation in 2010, an honor society for physician-scientists. She is listed in Castle and Connelly as one of America's Top Doctors, and is a Fellow of the American College of Physicians and the American Gastroenterological Association.
Dr. Abreu has authored more than 100 peer-reviewed articles, books, chapters, and reviews. She serves on the editorial board of Inflammatory Bowel Diseases and Gastroenterology & Hepatology News, an AGA-sponsored publication. Dr. Abreu is an editor for the Journal of Immunology and is a reviewer for Gastroenterology and Nature Medicine, in addition to many other journals. She is a standing member of the NIH Gastrointestinal Mucosal Pathobiology Study Section (GMPB) and is a member of the CCFA Research Initiatives Committee. Her research interest is host-bacterial interactions and, in particular, the role of toll-like receptor signaling in intestinal inflammation and colon cancer. Her translational work has focused on genotype-phenotype relationships in inflammatory bowel disease and prediction of response to medical therapies. Dr. Abreu is a frequent speaker at national and international symposia on basic science and clinical topics.
Maria T. Abreu, ...
www.reachmd.com, 17 Jan 2014 [cached]
Maria T. Abreu, MD
...
Maria T. Abreu, MD Dr. Maria T. Abreu is professor of medicine and chief, division of gastroenterology, at the University of Miami Miller School of Medicine in Florida.... more
...
Maria T. Abreu, MD Chief, Division of Gastroenterology Professor of Medicine University of Miami
...
Dr. Abreu serves as a consultant for Abbott Laboratories, Bristol-Myers Squibb, Hospira, Inc., Merck, Pfizer, Inc., Sanofi-Aventis, and UCB, Inc.
Our Team
www.mountsinai.org, 27 Sept 2005 [cached]
Maria T. Abreu, MD, Director, Center for Inflammatory Bowel DiseasesDr. Abreu specializes in inflammatory bowel disease (IBD).Before joining the faculty at Mount Sinai, she had served as Director of Basic and Translational Research in the Inflammatory Bowel Disease Center at Cedars-Sinai.For her, Mount Sinai was a particularly exciting destination.
"Mount Sinai is famous in IBD both historically and in the present," says Dr. Abreu.
...
All of these components are a perfect fit for Dr. Abreu.
While she devotes most of the week to basic science and clinical research related to IBD, she also sees patients one day a week."I see IBD patients and patients with unusual GI disorders, for whom I'm often asked to give a second opinion."
In Dr. Abreu's lab, she is interested in the question of how the intestine copes with bacteria."We don't all have GI illnesses," she explains."We know that the intestine usually coexists happily with bacteria and there is no GI inflammation.With IBD, something has been disrupted."Dr. Abreu's current research focuses on the regulation of toll-like receptors, the receptors that recognize bacteria, in intestinal cells.She is also interested in the genetics of IBD and, as she points out, is working with world-class geneticists in the Department of Human Genetics.In addition, Dr. Abreu is interested in new biologic therapies for IBD that work on the mucosal immune system."What makes some people respond to certain therapies and others not?"she asks.
Other People with the name "Abreu":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.